Effects of tacrolimus (FK506) and mycophenolate mofetil (MMF) on regulatory T cells and co-inhibitory receptors in the peripheral blood of human liver allograft patients

References

• Sotiropoulos GC, Vernadakis S, Paul A, et al. Single-center experience on liver transplantation for model for end-stage liver disease score 40 patients. Digest Dis & Sci. 2016;61:1–8.
   PubMed Web of Science ®Google Scholar
• Chan SC, Tan TC, Chan ACY, et al. New insights after the first 1000 liver transplantations at The University of Hong Kong. Asian J Surg. 2016;39:202–210.
   PubMed Web of Science ®Google Scholar
• Huang YY, Hsu CC, Chou CL, et al. Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study. Pharmacoepidemiol Drug Saf. 2016;25:661–667.
   PubMed Web of Science ®Google Scholar
• Ma B, Yang JY, Song WJ, et al. Combining exosomes derived from immature dcs with donor antigen-specific treg cells induces tolerance in a rat liver allograft model. Sci Rep. 2016;6:32971.
   PubMed Web of Science ®Google Scholar
• Anderson A, Joller N, Kuchroo V. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity. 2016;44:989–1004.
   PubMed Web of Science ®Google Scholar
• Stecher C, Battin C, Leitner J, et al. PD-1 blockade promotes emerging checkpoint inhibitors in enhancing T cell responses to allogeneic dendritic cells. Front Immunol. 2017;8:572.
   PubMed Web of Science ®Google Scholar
• Davis RJ, Ferris RL, Schmitt NC. Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations. Cancers Head Neck. 2016;1:12.
   PubMedGoogle Scholar
• Attanasio J, Wherry EJ. Costimulatory and coinhibitory receptor pathways in infectious disease. Immunity. 2016;44:1052–1068.
   PubMed Web of Science ®Google Scholar
• Yasuma K, Yasunaga J, Takemoto K, et al. HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT). Plos Pathog. 2016;12:e1005372.
   PubMed Web of Science ®Google Scholar
• Hwang S, Ahn CS, Kim KH, et al. A cross-sectional analysis of long-term immunosuppressive regimens after liver transplantation at Asian Medical Center: increased preference for mycophenolate mofetil. Ann Hepatobiliary Pancreat Surg. 2018;22:19–26.
   PubMedGoogle Scholar
• Kaya Z, Egritas O, Dalgic B. Tacrolimus-induced autoimmune hemolytic anemia in a previously reported child with history of thrombocytopenia following liver transplant. Exp Clin Transplant. 2018;16:355–356.
   PubMed Web of Science ®Google Scholar
• Ling G, Lamprecht S, Shubinsky G, et al. Mycophenolate mofetil alone and in combination with tacrolimus inhibits the proliferation of HT-29 human colonic adenocarcinoma cell line and might interfere with colonic tumorigenesis. Anticancer Res. 2018;38:3333–3339.
   PubMed Web of Science ®Google Scholar
• Kim JH, Han N, Kim MG, et al. Increased exposure of tacrolimus by co-administered mycophenolate mofetil: population pharmacokinetic analysis in healthy volunteers. Sci Rep. 2018;8:1687.
   PubMed Web of Science ®Google Scholar
• D'Avola D, Cuervas-Mons V, Martí J, et al. Cardiovascular morbidity and mortality after liver transplantation: the protective role of mycophenolate mofetil. Liver Transpl. 2017;23:498–509.
   PubMed Web of Science ®Google Scholar
• Efe C, Hagström H, Ytting H, et al. Efficacy and safety of mycophenolate mofetil and tacrolimus as second-line therapy for patients with autoimmune hepatitis. Clin Gastroenterol Hepat. 2017;15:1950–1956.
   PubMed Web of Science ®Google Scholar
• Matthias K, Tobias B. Cyclic AMP represents a crucial component of Treg cell-mediated immune regulation. Front Immunol. 2016;7:315.
   PubMed Web of Science ®Google Scholar
• Pervinder S, Giovanna L, Lechler RI. Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation. Front Immunol. 2012;3:184.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Zhou XY, et al. CD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+ TREG cells. J Exp Med. 203, 1701–1711.
   PubMed Web of Science ®Google Scholar
• Nabila S, Brigitte SN, Jeff M, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006;203:1693–1700.
   PubMed Web of Science ®Google Scholar
• Bakrac M, Jurisic V, Kostic T, et al. Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature. J Clin Pathol. 2007;60: 717–720.
   PubMed Web of Science ®Google Scholar
• Gallon L, Traitanon O, Yu Y, et al. Differential effects of calcineurin and mammalian target of rapamycin inhibitors on alloreactive Th1, Th17, and regulatory T cells. Transplantation. 2015;99:1774–1784.
   PubMed Web of Science ®Google Scholar
• Lim DG, Koo SK, Park YH, et al. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation. Transplantation. 2010;89:928.
   PubMed Web of Science ®Google Scholar
• Gandolfo MT, Jang HR, Bagnasco SM, et al. Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion. Transpl Immunol. 2010;23:45–52.
   PubMed Web of Science ®Google Scholar
• Demirkiran A, Sewgobind VD, Van dWJ, et al. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells. Transplantation. 2009;87:1062–1068.
   PubMed Web of Science ®Google Scholar
• Guillot C, Mathieu P, Coathalem H, et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol. 2000;164:5258–5268.
   PubMed Web of Science ®Google Scholar
• Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704.
   PubMed Web of Science ®Google Scholar
• Gupta S, Thornley TB, Gao W, et al. Allograft rejection is restrained by short-lived TIM-3 + PD-1 + Foxp3+ Tregs. J Clin Invest. 2012;122:2395–2404.
   PubMed Web of Science ®Google Scholar
• Burton BR, Britton GJ, Fang H, et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nature Commun. 2014;5:4741.
   PubMed Web of Science ®Google Scholar
• Amarnath S, Mangus CW, Wang JC, et al. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci Transl Med. 2011;3:111ra20.
   Web of Science ®Google Scholar
• Fuhrman CA, Yeh WI, Seay HR, et al. Divergent phenotypes of human regulatory T Cells expressing the receptors TIGIT and CD226. JI. 2015;195:145–155.
   Google Scholar
• Mehling A, Grabbe S, Voskort M, et al. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol. 2000;165:2374–2381.
   PubMed Web of Science ®Google Scholar
• Pallotta MT, Orabona C, Volpi C, et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol. 2011;12:870.
   PubMed Web of Science ®Google Scholar
• Regateiro FS, Howie D, Cobbold SP, et al. TGF-β in transplantation tolerance. Curr Opin Immunol. 2011;23:660–669.
   PubMed Web of Science ®Google Scholar
• Weber M, Stein P, Prüfer S, et al. Donor and host B cell-derived IL-10 contributes to suppression of graft-versus-host disease. Eur J Immunol. 2014;44:1857–1865.
   PubMed Web of Science ®Google Scholar
• Li J, Lai X, Liao W, et al. The dynamic changes of Th17/Treg cytokines in rat liver transplant rejection and tolerance. Int Immunopharmacol. 2011;11:962–967.
   PubMed Web of Science ®Google Scholar
• Tan CQ, Gao X, Guo L, et al. Exogenous IL-4-expressing bone marrow mesenchymal stem cells for the treatment of autoimmune sensorineural hearing loss in a Guinea pig model. Biomed Res Int. 2014;2014:1.
   Web of Science ®Google Scholar
• Cai L, Zhou H, Fang Z, et al. Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice. Transplantation. 2013;96:379–386.
   PubMed Web of Science ®Google Scholar
• Li D, Tsang JYS, Peng J, et al. Adiponectin mediated MHC Class II mismatched cardiac graft rejection in mice is IL-4 dependent. Plos One. 2012;7:e48893.
   PubMed Web of Science ®Google Scholar